CAN
RXRX icon

Cetera Advisor Networks’s Recursion Pharmaceuticals RXRX Stock Holding History

Cetera Advisor Networks’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$273K Sell
27,431
-9,197
-25% -$102K ﹤0.01% 2355
2023
Q4 		$361K Buy
+36,628
New +$261K ﹤0.01% 2108

Other funds holding RXRX

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $34.8B AUM 107.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cetera Advisor Networks's RXRX Position: Q1 2024 in Review

Cetera Advisor Networks reduced its Recursion Pharmaceuticals (RXRX) stake by 25% in Q1 2024, selling an estimated $102K and leaving 27,431 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #2355.

Cetera Advisor Networks first reported a position in RXRX in Q4 2023 and has held it in 2 quarters since. The position peaked at $361K in Q4 2023. 249 funds tracked by Wall St. Rank hold RXRX as of Q1 2024.

  • Cetera Advisor Networks held 27,431 shares of Recursion Pharmaceuticals worth $273K as of Q1 2024.
  • Cetera Advisor Networks sold 9,197 Recursion Pharmaceuticals shares in Q1 2024, an estimated $102K.
  • Recursion Pharmaceuticals made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2355 holding.
  • Cetera Advisor Networks first reported a position in Recursion Pharmaceuticals in Q4 2023 and has held it in 2 quarters since.
  • Cetera Advisor Networks's Recursion Pharmaceuticals position peaked at $361K in Q4 2023.
  • 249 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.